Expert Details
Cardiovascular Research, Pharmacology, Toxicology, Pathology, Expert witness consulting
ID: 731121
Canada
conducted with Expert Richard Haslam at McMaster University in Hamilton, Canada. After graduation, he carried out Medical Research
Council of Canada-funded postdoctoral studies in the laboratory University of North Carolina, Chapel Hill, USA.
Expert joined Queen's University in 1994 as Assistant Professor in the Departments of Pathology & Molecular Medicine and
Pharmacology & Toxicology. Expert's work has resulted in the publication of 50 scientific manuscripts, focusing on the role of
phosphodiesterases in the cardiovascular system, particularly with respect to erectile dysfunction. He is a member of the Editorial
Board of Molecular Pharmacology, and a grant reviewer on the Cardiovascular Sciences Committee of the Canadian Institutes for
Health Research of Canada Open Suite of Programs.
Expert has experience as ''Consulting Expert'' and " Expert Witness" representing multiple firms.
From 2001-2007, Expert. Expert has done consulting for Bayer/GSK ''PDE5 Think Tank''.Expert. Expert is considered a ''Consulting Expert'' and " Expert Witness", representing Bayer-AG, Alelix, Novo-Pharm, Teva.
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 1990 | Degree: PhD | Subject: Medical Sciences | Institution: McMaster University |
| Year: 1985 | Degree: BSc | Subject: Biochemistry | Institution: Carleton Univerity |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 2008 to Present | Employer: Undisclosed | Title: Director | Department: Cardiac Circulatory and Respiratory (CCR) Research Program |
Responsibilities: |
|||
| Years | Employer | Title | Department |
| Years: 2006 to Present | Employer: Undisclosed | Title: Professor (Tenured) | Department: Department of Pharmacology and Toxicology |
Responsibilities: |
|||
Government Experience
| Years | Agency | Role | Description |
|---|---|---|---|
| Years: 2008 to Present | Agency: CIHR | Role: Operating Grant Review Panel, Cardiovascular Sciences Member | Description: |
| Years: 1994 to Present | Agency: CIHR | Role: Expert Reviewer | Description: He is currently an Expert Reviewer for grants submitted to Canadian Institutes of Health Research (CIHR). |
Career Accomplishments
| Associations / Societies |
|---|
| - Heart & Stroke Foundation of Ontario - PMAC-HRF/MRC - Canadian Pharmacology Society |
| Licenses / Certifications |
|---|
| Ph.D. |
| Professional Appointments |
|---|
| Circulatory and Respiratory (CCR) Research Program, Queen’s University at Kingston CIHR Operating Grant Review Panel, Cardiovascular Sciences (B) Scientific Review Committee” IVa”, Heart and Stroke Foundation of Canada Associate Professor, Department of Pharmacology and Toxicology, Queen’s University, Kingston, Ontario Associate Professor, Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario |
| Awards / Recognition |
|---|
| Heart and Stroke Foundation of Ontario Career Investigator Award-Renewed Merck-Frosst Award in Pharmacology, Pharmacological Society of Canada Heart and Stroke Foundation of Ontario Career Investigator Award Pharmaceutical Manufacturers Association of Canada/Health Research Foundation (PMAC/HRF)/Medical Research Council of Canada Career Award in Health Sciences Medical Research Council of Canada Postdoctoral Fellowship (accepted) |
| Publications and Patents Summary |
|---|
| Multiple patents and publications. |
Additional Experience
| Expert Witness Experience |
|---|
| ''Consulting Expert'' and " Expert Witness" representing Bayer-AG, Alelix, Novo-Pharm, Teva. |
| Training / Seminars |
|---|
| Gordon Research Conferences, “Cyclic Nucleotide Phosphodiesterases”, 46th Annual Meeting /46e Congrès Annuel, Canadian Federation of Biological Societies/Fédération Canadienne des Sociétés de Biologie, Symposium 2:Diabetes and Atherosclerosis, Ottawa, Ontario, Canada Gordon Research Conferences, “Cyclic Nucleotide Phosphodiesterases”, Mount Holyoak, MA, U.S.A |
| Marketing Experience |
|---|
| Bayer/GSK ''PDE5 Think Tank'' (2001-2007) |
Fields of Expertise
blood flow, blood vessel, cardiovascular disease, cardiovascular drug therapy, cardiovascular pharmacology, cardiovascular physiology, cardiovascular research, cardiovascular system, expert testimony, expert witness, heart disease, heart disease risk, molecular cardiology, pharmacology, vascular disease, vasoconstrictor agent, cardiomyopathies, erection, cardiac electrophysiology, biochemical pharmacology, legal litigation support, sexual dysfunction, vasodilator, nitric oxide, molecular pharmacology, antihypertensive drug, physiology, heart, endocarditis, circulatory system, aortic disease